| abstract |
The invention relates to the novel human blood peptides, hBD-5 (human beta-defensin-5), hBD-7, hBD-8, hBD-10, hBD-11, hBD-12, hBD-13, hBD-14 , hBD-15, hBD-16, hBD-17, hBD-18, hBD-19, hBD-20, hBD-22, hBD-23, hBD-24, hBD-25, hBD-26, hBD-27, hBD -28, hBD-29, hBD-30, hBD-31 and hBD-32 and their derivatives, which has been elucidated in structure for therapeutic, diagnostic and commercial use as a drug. The peptides can be prepared proteolytically by means of biotechnological, recombinant methods, chemical synthesis and from corresponding precursor proteins. |